Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Diluted EPS of $0.27 per share (loss) for fiscal year 2024.
CHINA PHARMA HOLDINGS, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.27 | +70.3% |
| 2023 | -$0.91 | +75.9% |
| 2022 | -$3.78 | -410.8% |
| 2021 | -$0.74 | -111.4% |
| 2015 | -$0.35 | +61.5% |
| 2014 | -$0.91 | -97.8% |
| 2013 | -$0.46 | -518.2% |
| 2012 | $0.11 | -75.0% |
| 2011 | $0.44 | -18.5% |
| 2010 | $0.54 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.17 | +73.8% | -6.3% |
| June 30, 2025 | -$0.16 | +82.0% | +33.3% |
| March 31, 2025 | -$0.24 | +66.7% | +63.1% |
| September 30, 2024 | -$0.65 | -124.1% | +27.0% |
| June 30, 2024 | -$0.89 | -154.3% | -23.6% |
| March 31, 2024 | -$0.72 | -148.3% | -148.3% |
| September 30, 2023 | -$0.29 | -81.2% | +17.1% |
| June 30, 2023 | -$0.35 | -94.4% | -20.7% |
- CHINA PHARMA HOLDINGS, INC. showed an increase of +70.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2024 period, CHINA PHARMA HOLDINGS, INC.’s diluted eps has declined by 150.0% (from $0.54 per share to $0.27 per share (loss)).
- The most recent figure is from CHINA PHARMA HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: